Cargando…

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia

BACKGROUND: In the extracellular environment, lysophosphatidic acid (LPA) species are generated via autotaxin (ATX)-mediated hydrolysis of lysophospholipid precursors. Members of the LPA family are potent lipid mediators transmitting signals via six different G protein-coupled LPA receptors (LPAR1-6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plastira, Ioanna, Bernhart, Eva, Joshi, Lisha, Koyani, Chintan N., Strohmaier, Heimo, Reicher, Helga, Malle, Ernst, Sattler, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178949/ https://www.ncbi.nlm.nih.gov/pubmed/32326963 http://dx.doi.org/10.1186/s12974-020-01809-1

Ejemplares similares

Lysophosphatidic Acid Induces Aerobic Glycolysis, Lipogenesis, and Increased Amino Acid Uptake in BV-2 Microglia
por: Joshi, Lisha, et al.
Publicado: (2021)

Lysophosphatidic Acid Receptor 5 (LPA(5)) Knockout Ameliorates the Neuroinflammatory Response In Vivo and Modifies the Inflammatory and Metabolic Landscape of Primary Microglia In Vitro
por: Joshi, Lisha, et al.
Publicado: (2022)

1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype
por: Plastira, Ioanna, et al.
Publicado: (2016)

Inhibition of Autotaxin and Lysophosphatidic Acid Receptor 5 Attenuates Neuroinflammation in LPS-Activated BV-2 Microglia and a Mouse Endotoxemia Model
por: Joshi, Lisha, et al.
Publicado: (2021)

Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019)

Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype
por: Plastira, I., et al.
Publicado: (2017)

Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ(2)-mediated cell death
por: Koyani, Chintan N., et al.
Publicado: (2016)

Myeloperoxidase-Derived 2-Chlorohexadecanal Is Generated in Mouse Heart during Endotoxemia and Induces Modification of Distinct Cardiomyocyte Protein Subsets In Vitro
por: Prasch, Jürgen, et al.
Publicado: (2020)

Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells
por: Bernhart, Eva, et al.
Publicado: (2015)

15-deoxy-Δ(12,14)-PGJ(2) promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis
por: Koyani, Chintan N., et al.
Publicado: (2014)

Myeloperoxidase and Septic Conditions Disrupt Sphingolipid Homeostasis in Murine Brain Capillaries In Vivo and Immortalized Human Brain Endothelial Cells In Vitro
por: Goeritzer, Madeleine, et al.
Publicado: (2020)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

2-Chlorohexadecanoic acid induces ER stress and mitochondrial dysfunction in brain microvascular endothelial cells
por: Bernhart, Eva, et al.
Publicado: (2018)

Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro
por: Üllen, Andreas, et al.
Publicado: (2012)

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020)

Saxagliptin but Not Sitagliptin Inhibits CaMKII and PKC via DPP9 Inhibition in Cardiomyocytes
por: Koyani, Chintan N., et al.
Publicado: (2018)

Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons()
por: Nusshold, Christoph, et al.
Publicado: (2013)

Lysophosphatidic acid, LPA: a bad boy becomes good
por: Budnik, Lygia T
Publicado: (2003)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
por: Wocławek-Potocka, Izabela, et al.
Publicado: (2014)

Myeloperoxidase scavenges peroxynitrite: A novel anti-inflammatory action of the heme enzyme
por: Koyani, Chintan N., et al.
Publicado: (2015)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
por: Chryplewicz, Agnieszka, et al.
Publicado: (2019)

Role of lysophosphatidic acid receptor LPA(2 )in the development of allergic airway inflammation in a murine model of asthma
por: Zhao, Yutong, et al.
Publicado: (2009)

Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration?
por: Gross, Isabel, et al.
Publicado: (2019)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
por: Balijepalli, Pravita, et al.
Publicado: (2021)

LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis
por: Windischhofer, Werner, et al.
Publicado: (2012)

Lysophosphatidic acid receptors LPA(4) and LPA(6) differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes
por: Hata, Erina, et al.
Publicado: (2016)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)
por: Park, Eun Young, et al.
Publicado: (2012)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts
por: Cerutis, D. Roselyn, et al.
Publicado: (2014)

LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice
por: Wang, Fang, et al.
Publicado: (2020)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis
por: Puigdomenech-Poch, Maria, et al.
Publicado: (2021)

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
por: Su, Pan, et al.
Publicado: (2022)

15d-PGJ(2) Promotes ROS-Dependent Activation of MAPK-Induced Early Apoptosis in Osteosarcoma Cell In Vitro and in an Ex Ovo CAM Assay
por: Mikulčić, Mateja, et al.
Publicado: (2021)

Lysophosphatidic acid LPA(1) and LPA(3) receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice
por: Ueda, Hiroshi, et al.
Publicado: (2018)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

GPR92/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques
por: Khandoga, Anna L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fq64l3crn6td86sr03fd14dfua